NCT06158516 2023-12-06A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine TumorsChanghai HospitalPhase 2 Not yet recruiting100 enrolled
NCT05316480 2022-04-07Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine NeoplasmsFudan UniversityPhase 2 Not yet recruiting42 enrolled